US 2007/0190053 A1 · Treament of lupus nephritis with anti-CD40L compounds

Abstract

This invention relates to methods for treatment of nephritis associated with immune complex disease using anti-CD40L compounds. According to one embodiment of this invention, anti-CD40L compounds are administered to a patient with immune complex disease who has received a kidney allograft, to inhibit the development of immune complex glomerulonephritis within the grafted kidney.

Claims23

Dependent claims

A method of treating a patient with immune complex disease, comprising administering to the patient a therapeutically effective amount of an anti-CD40L compound.

Dependencies are inferred from the claim text.

Facts

Application

11/527,700Filed 25 Sep 2006

Priority

10 Jan 1997

Published

16 Aug 2007

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

C07K 16/2875
Against receptors, cell surface antigens or cell surface determinants: against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
A61P 9/14
Drugs for disorders of the cardiovascular system: vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
A61P 13/12
Drugs for disorders of the urinary system: of the kidneys
A61P 19/02
Drugs for skeletal disorders: for joint disorders, e.g. arthritis, arthrosis

Family

Application60/034,673Us provisional application · filed 10 Jan 1997

Application09/346,270Continuation · filed 1 Jul 1999

Application10/260,639Continuation · filed 27 Sep 2002

Application11/527,700Continuation · filed 25 Sep 2006

US 2003/0031668 A1Published application

US 2007/0190053 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

11/527,700Filed 25 Sep 2006

Priority

10 Jan 1997

Published

16 Aug 2007

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

C07K 16/2875
Against receptors, cell surface antigens or cell surface determinants: against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
A61P 9/14
Drugs for disorders of the cardiovascular system: vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
A61P 13/12
Drugs for disorders of the urinary system: of the kidneys
A61P 19/02
Drugs for skeletal disorders: for joint disorders, e.g. arthritis, arthrosis

Family

Application60/034,673Us provisional application · filed 10 Jan 1997

Application09/346,270Continuation · filed 1 Jul 1999

Application10/260,639Continuation · filed 27 Sep 2002

Application11/527,700Continuation · filed 25 Sep 2006

US 2003/0031668 A1Published application

US 2007/0190053 A1This patent

From the US filing history. Foreign family members aren’t listed.

Treament of lupus nephritis with anti-CD40L compounds

Life of this patent

Abstract

Claims23

Treament of lupus nephritis with anti-CD40L compounds

Life of this patent

Abstract

Claims23